Molecular Biomarkers of Primary and Acquired Resistance to T‐Cell‐Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions

The emergence of immunotherapy has revolutionized cancer treatment in recent years. Inhibitors of immune checkpoints, including antibodies against cytotoxic T‐lymphocyte‐associated protein 4, programmed cell death protein 1, and programmed death ligand 1, have demonstrated notable efficacy in certai...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncologist
Hauptverfasser: Chae, Young Kwang, Oh, Michael S., Giles, Francis J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2017
Schlagworte:
Cancer Diagnostics and Molecular Pathology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5896702/
https://ncbi.nlm.nih.gov/pubmed/29242279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0354
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge